Devonian Health Group Inc. (TSXV: GSD)
Health Care · Pharmaceuticals · CA
CA$8.25
+3.13% today · -45.0% 1Y
Devonian Health Group Inc. (TSXV: GSD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $16.08M and employs 11 people.
Over the last twelve months the share price has lost 45.0%, trading between 5.10 and 15.00.
Tweenvest scores Devonian Health Group Inc. across four factors: quality 47/100, value 41/100, growth 85/100. Its strongest factor is growth.
GSD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.08M
- Revenue (TTM)
- $2.20M
- P/E
- —
- EPS
- -2.26
- Dividend yield
- —
- Beta (5Y)
- 1.14
- 52-week high
- CA$15.00
- 52-week low
- CA$5.10
- Avg volume (3M)
- —
- Shares outstanding
- 2.78M
- Employees
- 11
- Next earnings
- —
About Devonian Health Group Inc.
Devonian Health Group, Inc. is a clinical-stage pharmaceutical company. The firm is engaged in the development of drugs for a range of autoimmune and fibroinflammatory conditions, using novel therapeutic approaches to address unmet medical needs. It offers therapeutic and cosmeceutical products. Its drug candidate, Thykamine product is issued from Devonian’s SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune disorders. The company was founded by Andre P. Boulet on March 27, 2015 and is headquartered in Montmagny, Canada.
- ISIN
- CA2518348834
- Founded
- 2017
- Listed since
- Oct 9, 2018
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PuraPharm Corporation LimitedSEHK: 1498 | $16.50M | HK$0.24 | -5.10% |
| MFC Co., Ltd.KOSE: A432980 | $16.33M | ₩2,555.00 | -2.11% |
| Rocket One Inc.NasdaqCM: RKTO | $16.17M | $0.65 | -6.94% |
| Kiora Pharmaceuticals, Inc.NasdaqCM: KPRX | $16.16M | $2.54 | -0.78% |
| Peak Processing LimitedASX: PKP | $15.83M | AU$0.02 | +6.25% |
| Otsuka Pakistan LimitedKASE: OTSU | $15.72M | PKRs359.78 | +0.79% |
| Bal Pharma LimitedBSE: 524824 | $15.32M | Rs93.15 | -11.79% |
| Auro Laboratories LimitedBSE: 530233 | $15.24M | Rs236.60 | -2.95% |
Figures last refreshed Oct 11, 2026.